cabergoline has been researched along with Glucose Intolerance in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Okazaki, K; Sugimoto, T; Takeno, A; Yamaguchi, T; Yamamoto, M | 1 |
| Bonaventura, MM; Calandra, RS; Huhtaniemi, IT; Lux-Lantos, VA; Poutanen, M; Ratner, LD; Rulli, SB; Stevens, G | 1 |
| Arany, E; Becu-Villalobos, D; Chamson-Reig, A; García-Tornadú, I; Hill, DJ; Ornstein, AM; Rubinstein, M; Wheeler, MB | 1 |
3 other study(ies) available for cabergoline and Glucose Intolerance
| Article | Year |
|---|---|
Successful Improvement of Metabolic Disorders, Including Osteopenia, by a Dopamine Agonist in a Male Patient with Macro-Prolactinoma.
Topics: Adult; Bone Diseases, Metabolic; Cabergoline; Dopamine Agonists; Ergolines; Glucose Intolerance; Humans; Hypertriglyceridemia; Male; Overweight; Pituitary Neoplasms; Prolactinoma | 2016 |
Hyperprolactinemia induced by hCG leads to metabolic disturbances in female mice.
Topics: Animals; Blood Glucose; Cabergoline; Chorionic Gonadotropin, beta Subunit, Human; Ergolines; Female; Glucose Intolerance; Hyperinsulinism; Hyperprolactinemia; Hypertriglyceridemia; Insulin; Insulin Resistance; Mice; Mice, Transgenic; Prolactin; Triglycerides | 2016 |
Disruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intolerance.
Topics: Analysis of Variance; Animals; Blood Glucose; Cabergoline; Cell Proliferation; Dopamine Agonists; Dopamine Antagonists; Ergolines; Female; Glucose; Glucose Intolerance; Haloperidol; Immunohistochemistry; Insulin; Insulin Secretion; Insulin-Like Growth Factor I; Male; Mice; Mice, Knockout; Pancreas; Prolactin; Radioimmunoassay; Receptors, Dopamine D2; Time Factors | 2010 |